Induction of c-fos protooncogene transcription and apoptosis by Δ12- prostaglandin J2 in human Pl-21 myeloid leukemia and RC-K8 pre-B lymphoma cells

Prostaglandins

Volumn 52, Issue 3, 1996, Pages 143-156

  Higashiyama, Ko Ichi ^a   Niiya, Kenji ^a,b   Ozawa, Tetsuo ^a   Hayakawa, Yumiko ^a   Fujimaki, Masao ^a   Sakuragawa, Nobuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; DELTA12 PROSTAGLANDIN J2; DNA FRAGMENT; MESSENGER RNA; PROSTAGLANDIN J2; PROTEIN C FOS;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG CYTOTOXICITY; ETIOLOGY; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOMA CELL; MYELOID LEUKEMIA; ONCOGENE C FOS; PRE B LYMPHOCYTE; PROTO ONCOGENE;

EID: 0030250298     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(96)00093-7     Document Type: Article

References (34)

1. 1. Santoro, M. G., Philpott, G. W., and Jaffe, B. M. Inhibition of tumour growth in vivo and in vitro by prostaglandin E. Nature, 263: 777. 1976.
2. 2. Honn, K. V., Dunn, J. 2., Morgan, L. R., Bienkowski, M., and Marnett, L. J. Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents. Biochem. Biophys. Res. Commun., 87: 795. 1979.
3. 3. Bregman, M. D., Sander, D., and Meyskens, F., Jr. Prostaglandin A1 and E1 inhibit the plating efficiency and proliferation of murine melanoma cells (Cloudman S-91) in soft agar. Biochem. Biophys. Res. Commun., 104: 1080. 1982.
4. 4. Fukushima, M., Kato, T., Ueda, R., Ota, K., Narumiya, S., and Hayaishi, O. Prostaglandin D2, a potential antineoplastic agent. Biochem. Biophys. Res. Commun., 105: 956. 1982.
5. 2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. Biochem. Biophys. Res. Commun., 127: 739. 1985.
6. 6. Bhuyan, B. K., Adams, E. G., Badiner, G. J., Li, L. H., and Barden, K. Cell cycle effects of prostaglandins A1, A2, and D2 in human and murine melanoma cells in culture. Cancer Res., 46: 1688. 1986.
7. 2 mimics heat shock in inducing cell cycle arrest at G1 phase. Biochem. Biophys. Res. Commun., 179: 1662. 1991.
8. 8. Kaufmann, S. H. Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res., 49: 5870. 1989.
9. 9. Gunji, H., Kharbanda, S., and Kufe, D. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabino-furanosylcytosine. Cancer Res., 51: 741. 1991.
10. 10. Kharbanda, S., Rubin, E., Gunji, H., Hinz, H., Giovanella, B., Pantazis, P., and Kufe, D. Camptothecin and its derivatives induce expression of the c-jun protooncogene in human myeloid leukemia cells. Cancer Res., 51: 6636. 1991.
11. 2 induce apoptosis in L1210 cells. FEBS Letters, 321: 209. 1993.
12. 12. van Straaten, F., Muller, R., Curran, T., Van Beveren, C., and Verma, I. M. Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. Proc. Natl. Acad. Sci. USA, 80: 3183. 1983.
13. 13. Kubonishi, L, Machida, K., Niiya, K., Sonobe, H., Ohtsuki, Y., Iwata, K., and Miyoshi, I. Establishment of a new peroxidase-positive human myeloid cell line, PL-21. Blood, 63: 254-. 1984.
14. 14. Kubonishi, I., Niiya, K., and Miyoshi, I. Establishment of a new human lymphoma line that secretes plasminogen activator. Jpn. J. Cancer Res., 76: 12. 1985.
15. 15. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55. 1983.
16. 16. Sambrook, J., Fritsh, E. F., and Maniatis, T. Molecular Cloning, A Laboratory Manual 2nd Ed. (2nd Ed. ed.) Cold Spring Harber Laboratory, 1989: p 7.39.
17. 17. Greenberg, M. E., and Ziff, E. B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature, 311: 433. 1984.
18. 18. Wyllie, A. H., Kerr, J. F., and Currie, A. R. Cell death: the significance of apoptosis. [Review]. Int. Rev. Cytol., 68: 251. 1980.
19. 19. Colotta, F., Polentarutti, N., Sironi, M., and Mantovani, A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem., 267: 18278. 1992.
20. 20. Ikai, K., and Imamura, S. Prostaglandin D2 in the skin. [Review]. Int. J. Dermatol., 27: 141. 1988.
21. 21. Ujihara, M., Urade, Y., Eguchi, N., Hayashi, H., Ikai, K., and Hayaishi, O. Prostaglandin D2 formation and characterization of its synthetases in various tissues of adult rats. Arch. Biochem. Biophys., 260: 521. 1988.
22. 22. Urade, Y., Ujihara, M., Horiguchi, Y., Ikai, K., and Hayaishi, O. The major source of endogenous prostaglandin D2 production is likely antigen-presenting cells. Localization of glutathione-requiring prostaglandin D synthetase in histiocytes, dendritic, and Kupffer cells in various rat tissues. J. Immunol., 143: 2982. 1989.
23. 23. Kikawa, Y., Narumiya, S., Fukushima, M., Wakatsuka, H., and Hayaishi, O. 9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc. Natl. Acad. Sci. USA, 81: 1317. 1984.
24. 24. Narumiya, S., and Fukushima, M. Site and mechanism of growth inhibition by prostaglandins. I. Active transport and intracellular accumulation of cyclopentenone prostaglandins, a reaction leading to growth inhibition. J. Pharmacol. Exp. Ther., 239: 500. 1986.
25. 25. Marui, N., Sakai, T., Hosokawa, N., Yoshida, M., Aoike, A., Kawai, K., Nishino, H., and Fukushima, M. N-myc suppression and cell cycle arrest at G1 phase by prostaglandins. FEBS Letters, 270: 15. 1990.
26. 26. Smeyne, R. J., Vendrell, M., Hayward, M., Baker, S. J., Miao, G. G., Schilling, K., Robertson, L. M., Curran, T., and Morgan, J. I. Continuous c-fos expression precedes programmed cell death in vivo [published erratum appears in Nature 1993 Sep 16;365(6443):279] [see comments]. Nature, 363: 166. 1993.
27. 27. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. [Review]. Biochim. Biophys. Acta, 1072: 129. 1991.
28. 28. McConkey, D. J., Orrenius, S., and Jondal, M. Agents that elevate cAMP stimulate DNA fragmentation in thymocytes. J. Immunol., 145: 1227. 1990.
29. 29. Shinbo, M., Niiya, K., Al-mokdad, M., Hayakawa, Y., Hiraga, K., Fujimaki, M., and Sakuragawa, N. Protein kinase activity-dependent inhibition of urokinase-type plasminogen activator gene transcription by cyclic AMP in human pre-B lymphoma cell line RC-K8. Biochim. Biophys. Acta, 1268: 293. 1995.
30. 2 receptor. Nature, 349: 617. 1991.
31. 31. Sugimoto, Y., Namba, T., Honda, A., Hayashi, Y., Negishi, M., Ichikawa, A., and Narumiya, S. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J. Biol. Chem., 267: 6463. 1992.
32. 32. Honda, A., Sugimoto, Y., Namba, T., Watabe, A., Irie, A., Negishi, M., Narumiya, S., and Ichikawa, A. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP2 subtype. J. Biol. Chem., 268: 7759. 1993.
33. 33. Sugimoto, Y., Hasumoto, K., Namba, T., Irie, A., Katsuyama, M., Negishi, M., Kakizuka, A., Narumiya, S., and Ichikawa, A. Cloning and expression of a cDNA for mouse prostaglandin F receptor. J. Biol. Chem., 269: 1356. 1994.
34. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J. Exp. Med., 178: 1825. 1993.